Viemed Healthcare US ( (VMD) ) has released its Q2 earnings. Here is a breakdown of the information Viemed Healthcare US presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Viemed Healthcare, Inc. is a U.S.-based in-home clinical care provider specializing in post-acute respiratory healthcare equipment and services, including non-invasive ventilators and sleep therapy. The company focuses on delivering efficient in-home treatment through high-touch and high-tech services.
Viemed Healthcare reported its financial results for the second quarter of 2025, showcasing significant growth and operational achievements. The company achieved record net revenues of $63.1 million, marking a 14.7% increase compared to the same period in 2024, alongside a notable rise in net income.
Key financial highlights include a 115.1% increase in net income to $3.2 million and an 11.5% rise in adjusted EBITDA to $14.3 million. The company also expanded its patient base, with ventilator and PAP therapy patient counts increasing by 11.4% and 51.4%, respectively. Additionally, Viemed completed the acquisition of Lehan’s Medical Equipment, which is expected to contribute positively to future financial results.
Looking ahead, Viemed has updated its full-year 2025 guidance, projecting net revenues between $271 million and $277 million and adjusted EBITDA between $59 million and $62 million. The company remains focused on growth and integration strategies, supported by a strong cash position and continued share repurchases.